Aldosterone augments LOX-1-mediated low-density lipoprotein uptake in human umbilical artery endothelial cells

Pharmacological Reports

Volumn 62, Issue 2, 2010, Pages 311-318

  Taye, Ashraf ^a   Sawamura, Tatsuya ^b   Morawietz, Henning ^c  

^a Minia University   (Egypt)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aldosterone; Endothelial cells; LOX 1; Spironolactone

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ALDOSTERONE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SPIRONOLACTONE; MINERALOCORTICOID ANTAGONIST; OLR1 PROTEIN, HUMAN;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HORMONE ACTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; UMBILICAL ARTERY; CELL CULTURE; GENETICS; METABOLISM; PHYSIOLOGY;

ALDOSTERONE; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E; UMBILICAL ARTERIES;

EID: 77953304402     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70271-1     Document Type: Article

References (37)

1. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science, 1987, 237, 268-275.
2. Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharmacol Rep, 2008, 60, 119-126.
3. Benard L, Milliez P, Ambroisine ML, Messaoudi S, Samuel JL, Delcayre C: Effects of aldosterone on coronary function. Pharmacol Rep, 2009, 61, 58-66.
4. Bodary PF, Sambaziotis C, Wickenheiser KJ, Rajagopalan S, Pitt B, Eitzman DT: Aldosterone promotes thrombosis formation after arterial injury in mice. Arterioscler Thromb Vasc Biol, 2006, 26, 233.
5. Caprio M, Newfell BG, la Sala A, Baur W, Fabbri A, Rosano G, Mendelsohn ME, Jaffe IZ: Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res, 2008, 102, 1359-1367.
6. Dworakowski R, Alom-Ruiz SP, Shah AM: NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep, 2008, 60, 21-28.
7. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y: Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol, 2006, 47, 609-613.
8. Iwashima F, Yoshimoto T, Minami I, Sakurada M, Hirono Y, Hirata Y: Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. Endocrinology, 2008, 149, 1009-1014.
9. Keidar S, Hayek T, Kaplan M, Pavlotzky E, Hamoud S, Coleman R, Aviram M: Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol, 2003, 41, 955-963.
10. Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M: Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation, 2004, 109, 2213-2220.
11. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest, 1995, 1262-1270.
12. Kita T, Kume N, Yokode M, Ishii K, Arai H, Horiuchi H, Moriwaki H et al.: Oxidized-LDL and atherosclerosis. Role of LOX-1. Ann NY Acad Sci, 2000, 902, 95-102.
13. Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K, Mita S et al.: Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKC-MAPK-p90RSK, and Rho-kinase pathway. Hypertension, 2005, 45, 538-544.
14. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature, 1990, 344, 160-162.
15. Kuhlmann D, Ragan C, Ferrebee JW, Atchley DW, Loeb RF: Toxic effects of desoxycorticosterone esters in dogs. Science, 1939, 90, 496-497.
16. Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, Kita T: Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res, 1998, 83, 322-327.
17. Lajemi M, Gautier S, Benetos A: Rigidity of large arteries and cardiovascular risk. Epidemiological aspects and genetic determinants (French). Pathol Biol (Paris), 1999, 47, 614-622.
18. Lehr HA, Becker M, Marklund SL, Hubner C, Arfors KE, Kohlschutter A, Messmer K: Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Thromb Vasc Biol, 1992, 12, 824-829.
19. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE: Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation, 1995, 91, 1525-1532.
20. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL: Upregulation of endothelial receptor for oxidized lowdensity lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res, 1999, 84, 1043-1049.
21. Li L, Sawamura T, Renier G: Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res, 2004, 94, 892-901.
22. Morawietz H, Erbs S, Holtz J, Schubert A, Krekler M, Goettsch W, Kuss O et al.: Endothelial protection, AT1 blockade and cholesterol-dependent oxidative stress: the EPAS trial. Circulation, 2006, 114, Suppl 1, 296-301.
23. Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K, Zerkowski HR et al.: Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation, 1999, 100, 899-902.
24. Taye A, Saad AH, Kumar AH, Morawietz H: Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol, 2010, 627, 42-46.
25. Nakamura Y, Suzuki S, Suzuki T, Ono K, Miura I, Satoh F, Moriya T et al.: MDM2: a novel mineralocorticoidresponsive gene involved in aldosterone-induced human vascular structural remodeling. Am J Pathol, 2006, 169, 362-371.
26. Rajagopalan S, Duquaine D, King S, Pitt B, Patel P: Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation, 2002, 105, 2212-2216.
27. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F: Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res, 2002, 11, 81-90.
28. Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK: Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology, 2000, 141, 3871-3878.
29. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801-809.
30. Rossi A, Baldo-Enzi G, Calabro A, Sacchetto A, Pessina AC, Rossi GP: The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension. J Hypertens, 2000, 18, 1401-1409.
31. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T et al.: An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997, 386, 73-77.
32. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C: Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem, 1998, 273, 4883-4891.
33. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem, 1997, 272, 20963-20966.
34. Steinberg D. Lewis A: Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis. Circulation, 1997, 95, 1062-1071.
35. Stier CT Jr, Chander PN, Rocha R: Aldosterone as a mediator in cardiovascular injury. Cardiol Rev, 2002, 10, 97-107.
36. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT: Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol, 2002, 161, 1773-1781.
37. Yoshimura M, Nakamura S, Ito T, Nakayama M, Harada E, Mizuno Y, Sakamoto T et al.: Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction. J Clin Endocrinol Metab, 2002, 87, 3936-3940.